Literature DB >> 32590410

Use of a Novel Couples' Verification Tool in a Male Partner Treatment Study of Women With Recurrent Bacterial Vaginosis.

Christina A Muzny1, Angela Pontius1, Nicole Woznicki2, Kathryn E Hudak3, Shelly Y Lensing4, Jack D Sobel2, Jane R Schwebke1.   

Abstract

Verification of relationship status beyond self-report is an important aspect in sexually transmitted infection research, including partner treatment studies where primary sexual partners are targeted for enrollment. This exploratory study describes the use of a novel couples' verification tool in a male partner treatment study of women with recurrent bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32590410      PMCID: PMC7669655          DOI: 10.1097/OLQ.0000000000001225

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   3.868


  18 in total

Review 1.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

2.  Couple-based HIV prevention for low-income drug users from New York City: a randomized controlled trial to reduce dual risks.

Authors:  Nabila El-Bassel; Louisa Gilbert; Elwin Wu; Susan S Witte; Mingway Chang; Jennifer Hill; Robert H Remien
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

3.  The validity of smoking self-reports by adolescents: a reexamination of the bogus pipeline procedure.

Authors:  D M Murray; C M O'Connell; L A Schmid; C L Perry
Journal:  Addict Behav       Date:  1987       Impact factor: 3.913

4.  Recruitment of minority women and their main sexual partners in an HIV/STI prevention trial.

Authors:  Susan S Witte; Nabila El-Bassel; Louisa Gilbert; Elwin Wu; Mingway Chang; Peter Steinglass
Journal:  J Womens Health (Larchmt)       Date:  2004-12       Impact factor: 2.681

5.  Recruiting and retaining couples for an HIV prevention intervention: lessons learned from the PARTNERS project.

Authors:  Katina A Pappas-DeLuca; Joan Marie Kraft; Sherri L Edwards; America Casillas; S Marie Harvey; Heather C Huszti
Journal:  Health Educ Res       Date:  2006-06-09

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis.

Authors:  J Swedberg; J F Steiner; F Deiss; S Steiner; D A Driggers
Journal:  JAMA       Date:  1985 Aug 23-30       Impact factor: 56.272

8.  The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis.

Authors:  M B Mengel; A O Berg; C H Weaver; D J Herman; S J Herman; V L Hughes; T D Koepsell
Journal:  J Fam Pract       Date:  1989-02       Impact factor: 0.493

9.  Methodological overview of an African American couple-based HIV/STD prevention trial.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2008-09-01       Impact factor: 3.731

10.  Association Between Financial Incentives and Participant Deception About Study Eligibility.

Authors:  Holly Fernandez Lynch; Steven Joffe; Harsha Thirumurthy; Dawei Xie; Emily A Largent
Journal:  JAMA Netw Open       Date:  2019-01-04
View more
  2 in total

Review 1.  Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections.

Authors:  Susan Tuddenham; Jacques Ravel; Jeanne M Marrazzo
Journal:  J Infect Dis       Date:  2021-06-16       Impact factor: 5.226

2.  Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jane R Schwebke; Shelly Y Lensing; Jeannette Lee; Christina A Muzny; Angela Pontius; Nicole Woznicki; Tina Aguin; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.